Abacus Planning Group’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-603
| Closed | -$8.06K | – | 219 |
|
|
2024
Q2 | $8.06K | Hold |
603
| – | – | ﹤0.01% | 218 |
|
|
2024
Q1 | $28K | Hold |
603
| – | – | 0.01% | 206 |
|
|
2023
Q4 | $40.8K | Hold |
603
| – | – | 0.01% | 199 |
|
|
2023
Q3 | $43.7K | Hold |
603
| – | – | 0.01% | 187 |
|
|
2023
Q2 | $44.9K | Hold |
603
| – | – | 0.01% | 196 |
|
|
2023
Q1 | $32.1K | Hold |
603
| – | – | 0.01% | 190 |
|
|
2022
Q4 | $40.8K | Hold |
603
| – | – | 0.01% | 178 |
|
|
2022
Q3 | $75K | Hold |
603
| – | – | 0.02% | 168 |
|
|
2022
Q2 | $57K | Hold |
603
| – | – | 0.02% | 187 |
|
|
2022
Q1 | $97K | Buy |
603
+224
| +59% | +$36K | 0.03% | 197 |
|
|
2021
Q4 | $126K | Hold |
379
| – | – | 0.03% | 203 |
|
|
2021
Q3 | $176K | Buy |
+379
| New | +$176K | 0.06% | 178 |
|